You'll need to sign in to follow to this podcast.
New to Podcast Chart? Sign up.
Audio interviews with industry leaders and senior faculty with exclusive insights on current topics brought to you by [email protected]
August 26th, 2016
Episode 608 of 734 episodes
Mylan, the now-infamous maker of the EpiPen allergy-treatment device, has raised outrage over out-sized price increases. Experts at Wharton and Penn Medicine explain the causes and the impact.
You'll need to sign in to write a comment.
Welcome to the daily audio workout for your head.
You'll need to sign in to add this to your collection.
Podcast Chart © 2017 Project Fantastic Ltd